Seyman, D. Et Al. 2014. Soluble TRAIL levels decreased in chronic hepatitis C treatment with pegylated interferon alpha plus ribavirin: association with viral responses. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.7, no.12 , 5650-5656.

Seyman, D., Yalcin, A. D., Oztoprak, N., Genc, G. E., Ozen, N. S., Kizilates, F., ... Berk, H.(2014). Soluble TRAIL levels decreased in chronic hepatitis C treatment with pegylated interferon alpha plus ribavirin: association with viral responses. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.7, no.12, 5650-5656.

Seyman, Derya Et Al. "Soluble TRAIL levels decreased in chronic hepatitis C treatment with pegylated interferon alpha plus ribavirin: association with viral responses," INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.7, no.12, 5650-5656, 2014

Seyman, Derya Et Al. "Soluble TRAIL levels decreased in chronic hepatitis C treatment with pegylated interferon alpha plus ribavirin: association with viral responses." INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.7, no.12, pp.5650-5656, 2014

Seyman, D. Et Al. (2014) . "Soluble TRAIL levels decreased in chronic hepatitis C treatment with pegylated interferon alpha plus ribavirin: association with viral responses." INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.7, no.12, pp.5650-5656.

@article{article, author={Derya Seyman Et Al. }, title={Soluble TRAIL levels decreased in chronic hepatitis C treatment with pegylated interferon alpha plus ribavirin: association with viral responses}, journal={INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE}, year=2014, pages={5650-5656} }